Chemed Price to Free Cash Flow Ratio 2010-2024 | CHE

Historical price to free cash flow ratio values for Chemed (CHE) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-04-24 546.78 22.36
2024-12-31 529.32 $24.45 21.65
2024-09-30 599.88 $20.81 28.83
2024-06-30 541.13 $16.83 32.15
2024-03-31 639.74 $19.87 32.20
2023-12-31 582.37 $18.03 32.30
2023-09-30 517.22 $17.06 30.32
2023-06-30 538.67 $18.52 29.08
2023-03-31 534.39 $13.91 38.41
2022-12-31 506.87 $16.88 30.03
2022-09-30 433.18 $14.56 29.76
2022-06-30 465.39 $18.45 25.23
2022-03-31 501.86 $16.13 31.11
2021-12-31 523.73 $15.74 33.28
2021-09-30 460.12 $17.04 27.00
2021-06-30 469.03 $17.50 26.80
2021-03-31 454.21 $27.61 16.45
2020-12-31 525.71 $26.35 19.95
2020-09-30 473.79 $25.04 18.92
2020-06-30 444.61 $25.12 17.70
2020-03-31 426.72 $15.61 27.34
2019-12-31 432.37 $15.02 28.79
2019-09-30 410.70 $14.33 28.67
2019-06-30 354.64 $13.06 27.15
2019-03-31 314.28 $14.44 21.76
2018-12-31 277.91 $13.94 19.93
2018-09-30 313.23 $9.00 34.82
2018-06-30 315.11 $7.14 44.16
2018-03-31 266.95 $5.42 49.26
2017-12-31 237.50 $5.87 40.49
2017-09-30 197.22 $8.18 24.12
2017-06-30 199.36 $7.03 28.37
2017-03-31 177.84 $9.50 18.72
2016-12-31 155.92 $5.70 27.38
2016-09-30 136.86 $8.51 16.08
2016-06-30 132.00 $7.57 17.43
2016-03-31 130.92 $6.84 19.13
2015-12-31 144.52 $7.31 19.77
2015-09-30 128.56 $7.40 17.36
2015-06-30 126.08 $5.22 24.15
2015-03-31 114.62 $5.05 22.70
2014-12-31 101.25 $3.74 27.08
2014-09-30 98.39 $1.32 74.74
2014-06-30 89.42 $4.15 21.53
2014-03-31 85.16 $5.30 16.06
2013-12-31 72.77 $6.54 11.13
2013-09-30 67.73 $8.69 7.80
2013-06-30 68.42 $6.94 9.85
2013-03-31 75.35 $5.22 14.44
2012-12-31 64.47 $4.99 12.92
2012-09-30 64.94 $5.52 11.77
2012-06-30 56.48 $7.11 7.95
2012-03-31 58.41 $4.86 12.01
2011-12-31 47.60 $6.91 6.89
2011-09-30 50.94 $4.94 10.31
2011-06-30 60.56 $3.93 15.40
2011-03-31 61.44 $4.49 13.69
2010-12-31 58.45 $2.62 22.30
2010-09-30 52.31 $4.85 10.79
2010-06-30 50.03 $4.88 10.26
2010-03-31 49.69 $5.21 9.55
2009-12-31 43.74 $6.13 7.14
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.501B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.282B 18.36
DaVita (DVA) United States $11.202B 14.29
Encompass Health (EHC) United States $10.408B 23.33
Option Care Health (OPCH) United States $5.259B 25.21
Elanco Animal Health (ELAN) United States $4.190B 9.27
RadNet (RDNT) United States $3.686B 79.02
Amedisys (AMED) United States $3.011B 21.29
LifeStance Health (LFST) United States $2.576B 0.00
Addus HomeCare (ADUS) United States $1.840B 21.32
Astrana Health (ASTH) United States $1.573B 35.26
U.S Physical Therapy (USPH) United States $1.025B 26.14
Pennant (PNTG) United States $0.907B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.886B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00